FabA is a promising drug target in Gram-negative bacteria.
High-throughput coupled assay for FabA using a substrate analogue has been developed.
New class of non-covalent inhibitor has been identified using the assay.
The compound inhibits the biological activity of FabA.
Crystal structure of the compound bound to FabA has been determined.